Update
$Biodexa Pharmaceuticals(BDRX.US$ Biodexa Pharmaceuticals Announces Phase 2 Trial Results Of ERapa In Familial Adenomatous Polyposis; 75% Non-Progression Rate At 12 Months, 17% Median Decrease In Polyp Burden; Cohort 2 Shows 81% Non-Progression And 29% Median Decrease Informing Phase...
Benzinga· 2 mins ago
Biodexa Pharmaceuticals Announces Phase 2 Trial Results Of ERapa In Familial Adenomatous Polyposis; 75% Non-Progression Rate At 12 Months, 17% Median Decrease In Polyp Burden; Cohort 2 Shows 81% Non-Progression And 29% Median Decrease Informing Phase 3 Dosage; Results Presented At 2024 InSIGHT Meeting
Benzinga· 2 mins ago
Biodexa Pharmaceuticals Announces Phase 2 Trial Results Of ERapa In Familial Adenomatous Polyposis; 75% Non-Progression Rate At 12 Months, 17% Median Decrease In Polyp Burden; Cohort 2 Shows 81% Non-Progression And 29% Median Decrease Informing Phase 3 Dosage; Results Presented At 2024 InSIGHT Meeting
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
EZ_money : you're here too
i bought the dip
TrytosaveabitOP EZ_money: But of course I am! Hehehe! Remember “great minds” hehehe. GL
好好♥ : drop?
EZ_money TrytosaveabitOP:
good luck 
TrytosaveabitOP 好好♥: Don’t fret yet! The volume is less than 100K and market not open yet! GL
好好♥ TrytosaveabitOP: For a while, I didn't know why it dropped to 0.99
。
好好♥ : My cost is 2.62
好好♥ : I bought what I lost, and I'm satisfied
TrytosaveabitOP 好好♥: Ok maybe fret a little bit! Hehehe! GL my average is 1.01!
TrytosaveabitOP 好好♥: Yes it is a decent place to average down if so inclined.
View more comments...